1. Home
  2. MYFW vs INDP Comparison

MYFW vs INDP Comparison

Compare MYFW & INDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

MYFW

First Western Financial Inc.

HOLD

Current Price

$33.19

Market Cap

320.1M

Sector

Finance

ML Signal

HOLD

Logo Indaptus Therapeutics Inc.

INDP

Indaptus Therapeutics Inc.

N/A

Current Price

$2.51

Market Cap

350.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
MYFW
INDP
Founded
2002
2000
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
320.1M
350.4M
IPO Year
2018
2021

Fundamental Metrics

Financial Performance
Metric
MYFW
INDP
Price
$33.19
$2.51
Analyst Decision
Hold
Analyst Count
1
0
Target Price
$27.00
N/A
AVG Volume (30 Days)
81.8K
152.2K
Earning Date
04-23-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
54.02
N/A
EPS
0.63
N/A
Revenue
$96,914,000.00
N/A
Revenue This Year
$20.48
N/A
Revenue Next Year
$9.70
N/A
P/E Ratio
$54.02
N/A
Revenue Growth
7.60
N/A
52 Week Low
$20.40
$0.92
52 Week High
$34.23
$12.03

Technical Indicators

Market Signals
Indicator
MYFW
INDP
Relative Strength Index (RSI) 59.70 44.50
Support Level $27.71 $2.42
Resistance Level $33.69 $3.11
Average True Range (ATR) 0.91 0.27
MACD -0.02 -0.08
Stochastic Oscillator 56.17 8.82

Price Performance

Historical Comparison
MYFW
INDP

About MYFW First Western Financial Inc.

First Western Financial Inc is a financial holding company that provides a fully integrated suite of wealth management services on its private trust bank platform, which includes a comprehensive selection of deposit, loan, trust, wealth planning, and investment management products and services. The company has two operating segments; The Wealth Management segment consists of operations relative to the Company's fully integrated wealth management products and services, and The Mortgage segment consists of operations relative to the Company's residential mortgage service offerings. The bank derives its majority revenue from the wealth management segment.

About INDP Indaptus Therapeutics Inc.

Indaptus Therapeutics Inc is a clinical biotechnology company that has developed a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy. Its approach is based on the hypothesis that efficient activation of both innate and adaptive immune cells and associated anti-tumor and anti-viral immune responses will require a multi-targeted package of immune system activating signals that can be administered safely intravenously. Its patented technology is composed of single strains of attenuated and killed, non-pathogenic, Gram-negative bacteria, designed to have reduced i.v. toxicity, but largely uncompromised ability to prime or activate many of the cellular components of innate and adaptive immunity. Its candidate, Decoy20 is for patients with solid tumors.

Share on Social Networks: